[Congressional Record Volume 162, Number 90 (Wednesday, June 8, 2016)]
[Senate]
[Pages S3650-S3651]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 4554. Mr. ISAKSON submitted an amendment intended to be proposed 
by him to the bill S. 2943, to authorize appropriations for fiscal year 
2017 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

       At the end of subtitle I of title X add the following:

     SEC. 1097. ADVANCING RESEARCH FOR NEUROLOGICAL DISEASES.

       Part P of title III of the Public Health Service Act (42 
     U.S.C. 280g et seq.) is amended by inserting after section 
     399S, the following:

     ``SEC. 399S-1. ADVANCING RESEARCH FOR NEUROLOGICAL DISEASES.

       ``(a) In General.--The Secretary may improve the collection 
     of epidemiological and surveillance data on neurological 
     diseases (including, for purposes of this section, both 
     neurological diseases and neurological conditions), which may 
     include the incorporation of such data into a registry, to 
     facilitate research and improve public health, including, as 
     appropriate, by leveraging existing surveillance activities 
     and registries established under this Act.
       ``(b) Content.--In carrying out subsection (a), the 
     Secretary--
       ``(1) shall provide for the collection and storage of 
     information to better describe the incidence and prevalence 
     of neurological diseases in the United States identified 
     under paragraph (2);
       ``(2) shall initially identify and focus on up to five 
     neurological diseases that available data indicate are the 
     most prevalent or present a significant public health burden;
       ``(3) shall identify, build upon, leverage, and coordinate 
     among existing data and surveillance systems, surveys, 
     registries, and other existing Federal public health and 
     infrastructure wherever possible;
       ``(4) shall ensure that any neurological disease 
     surveillance activities conducted pursuant to this section, 
     including any such registry, are designed in a manner that 
     facilitates research on neurological diseases;
       ``(5) shall, to the extent practicable, provide for the 
     collection and storage of information relevant to the 
     identified neurological diseases, such as--
       ``(A) demographics, such as age, race, ethnicity, sex, 
     geographic location, and family history, and other 
     information, as appropriate;
       ``(B) risk factors that may be associated with certain 
     neurological diseases; and
       ``(C) diagnosis and progression markers;
       ``(6) may provide for the collection and storage of 
     additional information relevant to analysis on neurological 
     diseases, such as information regarding--
       ``(A) the natural history of the diseases;
       ``(B) the prevention, detection, management, and treatments 
     or treatment approaches for the diseases; and
       ``(C) the development of outcomes measures; and
       ``(7) may address issues identified during the consultation 
     process described in subsection (c).
       ``(c) Consultation.--In carrying out this section, the 
     Secretary shall consult with experts, who may include--
       ``(1) epidemiologists with experience in disease 
     surveillance or registries;
       ``(2) representatives of national and voluntary health 
     associations that focus on neurological diseases and have 
     demonstrated experience in research, care, or patient 
     services;
       ``(3) health information technology experts or other 
     information management specialists;
       ``(4) clinicians with expertise in neurological diseases; 
     and
       ``(5) research scientists with experience conducting 
     translational research or utilizing surveillance systems or 
     registries for scientific research purposes.
       ``(d) Grants.--The Secretary may award grants to, or enter 
     into contracts or cooperative agreements with, public or 
     private nonprofit entities to carry out activities under this 
     section.
       ``(e) Coordination With Other Federal Agencies.--Consistent 
     with applicable privacy laws, the Secretary shall make 
     information and analysis pertaining to information collected 
     under this section available, as appropriate, to relevant 
     Federal departments and agencies.
       ``(f) Access for Biomedical Research.--The Secretary shall 
     make data collected under this section available for purposes 
     of

[[Page S3651]]

     biomedical research as determined appropriate by the 
     Secretary, to the extent permitted by applicable laws, and in 
     a manner that protects personal privacy.
       ``(g) Reports.--
       ``(1) Interim report.--Not later than 1 year after the date 
     on which any registry is established and operational under 
     this section, the Secretary shall submit an interim report to 
     the Committee on Health, Education, Labor, and Pensions of 
     the Senate and the Committee on Energy and Commerce of the 
     House of Representatives regarding aggregate information 
     collected pursuant to this section and epidemiological 
     analyses, as appropriate. Such report shall be posted on the 
     Internet website of the Department of Health and Human 
     Services and shall be updated biennially thereafter.
       ``(2) Implementation report.--Not later than 4 years after 
     the date of the enactment of this section, the Secretary 
     shall submit a report to the Committee on Health, Education, 
     Labor, and Pensions of the Senate and the Committee on Energy 
     and Commerce of the House of Representatives regarding the 
     implementation of this section. Such report shall include 
     information on--
       ``(A) the development and maintenance of any means of 
     collecting neurological disease surveillance information 
     gathered pursuant to this section;
       ``(B) the type of information collected and stored;
       ``(C) the use and availability of such information, 
     including guidelines for such use; and
       ``(D) the use and coordination of databases that collect or 
     maintain information on neurological diseases.''.
                                 ______